PDFファイル - 医薬品医療機器総合機構
Contents
1. 7 2 8 2 20C 8 2 2000 L2M2Z 200U mL 2 1 200mgL 2 512mg dL 3 3 000mgjmL 2015 7 5 2013 4 4 3 2000 2000XPi2. jt 2 3 PPD 1 2 3 4 4 5 6 7 3 1 HIV HBV HCV
3. 1 1 UmL IL 1g 10 000 ND IL 2 10 000 ND IL 4 10 000 ND IL 6 10 000 ND IL 8 10 000 ND IL 18 10 000 ND 10 000 ND TNFa 10 000 ND ND 4 2 8 C 90 2 28 90 3 L H 1 3 0mL 2 8
4. 2 TL 2R 2 2 ALP LL 2R 3 L 4 H 5 PPD 4 4 3 1 2 3 2 2 UL 2R 1 CLEIA 2 IL 2R IL 2R ALP LL 2R 4 4
5. 1 000ppm 1 2 1 121C 20 2 0 1 3 4 1 2 8 C 2 1 L2KIP2 200 2 200
6. 21700AMY00148000 L2KIP2 L2KIP6 2000 IL 1a IL1b ILI1IRA IL2r IL6r IL 2R I 2000XPi 1 2 3 4 5 6 7
7. UjmL 1 1 100 9596 158 623U mL 333UJmL 2 157 127 582U ml 2 1 2 2 x 1
8. y n 55 r 0 998 y 0 99 x 9 03 3 1000 y 130 6 990U mL n 131 r 0 995 y 1 03 x 5 5 767U mL 736U7mL 1000 8 Soluble Interleukin 2 Receptor 1 1 HTV 1 2 HBs HCV HIV HBV HCV 2 3 0 1 2
9. 03 3493 8400 1 11 1 10381457M1_04 PINL2KIP 1 9 2009 08 03
10. 11 5mL x 1 1 L 3 0mL x 2 3 H 3 0mL x 2 3 12KIP6 600 2 600 11 5mL x 3 1 L 3 0mL x 2 3 H 3 0mL x 2 3 L2SUBM PPD 205mL x 2 1 1 2 Boscato LM Stuart MC Heterophilic antibodies a problem for all immunoassays Clin Chem 1988 34 27 33 3 2000 23 3 199 201 1998 4 IMMULYZE1000 2 SIL 2R 27 3 201 206 2004 1000 2 sIL 2R 51 5 731 735 2004 6 2 sIL 2R 54 6 889 894 2005 5
11. 1 0U mL 2 000U mL 2 000U mL OU mL 50 2 20 3 5 C V 15 4 50 7 500U mL 2 5U mL 3 1 030 000U mI 4 1 2 2 20 40 80 C V 2 5 3 4 C V 3 6 4 4 5 IL 2R 56807U mL 72 97 6 1 19 IL 2R 5 000 25 000 50 000 U mL 93 136 7 1 1 y n 58 r 0 999 y 1 00 x 2 02 2
12. 3 1 2 3 2 PPD PPD ALP IL 2R i 1 EDTA 2 1 15 pL 250 plL 265 kL 3 4 5 6
13. 3 4 PPD 15 28 20 15 28 30 5 2 2000 2M2Z 16 x100mm 2 8C 30 20 6 6 2000 L2PWSM 2 3 2000 2000XPil 12R 1
14. 15 gL 50 pL 37 30 PPD 200 Lt 37 5 5 L IL 2R 4 1 LL H 2 3 LL H 4 5 1 2 Low High 2
Download Pdf Manuals
Related Search